|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.20 EUR | -0.76% |
|
-1.50% | -5.76% |
| 05-29 | HAEMATO AG announces Annual dividend, payable on July 10, 2026 | CI |
| 01-31 | PHOENIX Pharmahandel SE completed the acquisition of HAEMATO Pharm GmbH from HAEMATO AG. | CI |
| Market Cap | 67.96M 77.75M 62.85M 57.67M 109M 7.49B 111M 750M 294M 3.66B 292M 286M 12.63B | P/E 2023 * |
-
| P/E 2024 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 67.96M 77.75M 62.85M 57.67M 109M 7.49B 111M 750M 294M 3.66B 292M 286M 12.63B | EV / Sales 2023 * |
-
| EV / Sales 2024 * | - |
| Free-Float |
99.67% | Yield 2023 * |
-
| Yield 2024 * | - |
| 1 day | -0.76% |
| Manager | Title | Age | Since |
|---|---|---|---|
Patrick Brenske
CEO | Chief Executive Officer | - | 30/11/2020 |
Attila Strauss
PRN | Corporate Officer/Principal | - | 01/04/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrea Grosse
CHM | Chairman | 61 | 30/05/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.76% | -1.50% | - | - | 77.75M | |
| +3.25% | +2.05% | +54.83% | +18.90% | 315B | |
| -1.38% | -2.61% | +21.96% | -8.57% | 68.62B | |
| +2.27% | -1.37% | +33.67% | +102.88% | 9.2B | |
| +0.34% | +0.51% | +4.67% | -0.69% | 8.52B | |
| -3.05% | +0.42% | +6.92% | +28.13% | 4.04B | |
| +1.53% | -1.00% | -18.56% | +3.79% | 4.2B | |
| +1.87% | +5.04% | -37.18% | +24.94% | 3.56B | |
| +1.01% | -1.11% | +43.82% | +60.54% | 2.8B | |
| -0.81% | +7.81% | +12.16% | -16.29% | 2.26B | |
| Average | +0.43% | -0.77% | +13.59% | +23.74% | 46.49B | |
| Weighted average by Cap. | +2.28% | -1.76% | +45.67% | +15.92% |
| 2023 * | 2024 * | |
|---|---|---|
| Net sales | - | - |
| Net income | - | - |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- HAEK Stock
- HAE Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
